BioLife Total Stockholder Equity vs Accumulated Depreciation Analysis
BLFS Stock | USD 18.01 0.07 0.39% |
BioLife Solutions financial indicator trend analysis is way more than just evaluating BioLife Solutions prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioLife Solutions is a good investment. Please check the relationship between BioLife Solutions Total Stockholder Equity and its Accumulated Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.
Total Stockholder Equity vs Accumulated Depreciation
Total Stockholder Equity vs Accumulated Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioLife Solutions Total Stockholder Equity account and Accumulated Depreciation. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between BioLife Solutions' Total Stockholder Equity and Accumulated Depreciation is -0.36. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Accumulated Depreciation in the same time period over historical financial statements of BioLife Solutions, assuming nothing else is changed. The correlation between historical values of BioLife Solutions' Total Stockholder Equity and Accumulated Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of BioLife Solutions are associated (or correlated) with its Accumulated Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accumulated Depreciation has no effect on the direction of Total Stockholder Equity i.e., BioLife Solutions' Total Stockholder Equity and Accumulated Depreciation go up and down completely randomly.
Correlation Coefficient | -0.36 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Accumulated Depreciation
Accumulated depreciation is the total amount of depreciation for BioLife Solutions fixed asset that has been charged to BioLife Solutions expense since that asset was acquired and made available for BioLife Solutions use. The accumulated depreciation account is BioLife Solutions asset account with a credit balance. It is also known as a contra asset account and appears on the balance sheet as a reduction from the gross amount of fixed assets reported by BioLife Solutions.Most indicators from BioLife Solutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 753.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 52.9 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 68.1M | 93.7M | 99.1M | 104.1M | Cost Of Revenue | 81.4M | 107.9M | 101.7M | 106.8M |
BioLife Solutions fundamental ratios Correlations
Click cells to compare fundamentals
BioLife Solutions Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BioLife Solutions fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 93.0M | 234.8M | 552.6M | 450.2M | 412.7M | 433.3M | |
Other Current Liab | 3.5M | 9.2M | 20.4M | 23.8M | 24.6M | 25.8M | |
Total Current Liabilities | 7.8M | 15.6M | 40.0M | 44.6M | 42.2M | 44.3M | |
Total Stockholder Equity | 83.0M | 205.2M | 480.8M | (246.9M) | 337.7M | 354.5M | |
Property Plant And Equipment Net | 6.6M | 19.8M | 36.8M | 39.2M | 32.6M | 34.2M | |
Net Debt | (5.1M) | (79.3M) | (43.0M) | 24.3M | 7.3M | 7.6M | |
Retained Earnings | (100.1M) | (97.4M) | (105.0M) | (246.9M) | (313.3M) | (297.7M) | |
Cash | 6.4M | 90.5M | 69.9M | 19.4M | 35.4M | 37.2M | |
Non Current Assets Total | 68.8M | 120.1M | 426.7M | 311.8M | 292.1M | 306.7M | |
Non Currrent Assets Other | 3.9M | 4.7M | 9.8M | 9.3M | 273K | 259.4K | |
Other Assets | 50K | 120.1M | 426.7M | 386.2M | 444.1M | 466.3M | |
Cash And Short Term Investments | 6.4M | 90.5M | 69.9M | 64.1M | 51.7M | 54.3M | |
Common Stock Shares Outstanding | 19.5M | 27.3M | 38.5M | 42.5M | 43.7M | 45.9M | |
Liabilities And Stockholders Equity | 93.0M | 234.8M | 552.6M | (160.9M) | 412.7M | 433.3M | |
Other Current Assets | 13.1M | 103.1M | 97.5M | 74.4M | 6.8M | 11.7M | |
Other Stockholder Equity | 183.1M | 302.6M | 586.0M | 636K | 651.3M | 683.9M | |
Total Liab | 10.0M | 29.6M | 71.9M | 86.0M | 75.1M | 78.8M | |
Property Plant And Equipment Gross | 6.6M | 19.8M | 43.5M | 48.4M | 42.1M | 44.2M | |
Total Current Assets | 24.2M | 114.7M | 125.9M | 138.5M | 120.6M | 126.6M | |
Accounts Payable | 3.1M | 3.7M | 14.9M | 15.4M | 6.9M | 7.3M | |
Non Current Liabilities Total | 2.2M | 14.0M | 31.9M | 41.5M | 32.9M | 34.5M | |
Inventory | 11.1M | 11.6M | 28.3M | 34.9M | 43.5M | 45.6M | |
Net Receivables | 5.3M | 8.0M | 23.2M | 33.9M | 18.7M | 19.6M | |
Common Stock Total Equity | 14.0K | 19K | 21K | 33K | 38.0K | 35.1K | |
Common Stock | 21K | 33K | 42K | 43K | 45K | 36.6K | |
Property Plant Equipment | 1.3M | 5.6M | 24.5M | 46.6M | 53.6M | 56.3M | |
Other Liab | 41.1M | 14.0M | 31.9M | 2.6M | 3.0M | 2.8M | |
Net Tangible Assets | (12.2M) | 205.2M | 480.8M | 364.2M | 418.8M | 439.8M | |
Retained Earnings Total Equity | (74.0M) | (71.0M) | (100.1M) | (97.4M) | (87.6M) | (92.0M) | |
Capital Surpluse | 84.0M | 114.2M | 143.5M | 302.6M | 348.0M | 365.4M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioLife Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioLife Solutions' short interest history, or implied volatility extrapolated from BioLife Solutions options trading.
Pair Trading with BioLife Solutions
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLife Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Solutions will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to BioLife Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLife Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLife Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLife Solutions to buy it.
The correlation of BioLife Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLife Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLife Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLife Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.Note that the BioLife Solutions information on this page should be used as a complementary analysis to other BioLife Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for BioLife Stock analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is BioLife Solutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (1.52) | Revenue Per Share 3.277 | Quarterly Revenue Growth (0.26) | Return On Assets (0.08) |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.